Literature DB >> 25154413

Two histone/protein acetyltransferases, CBP and p300, are indispensable for Foxp3+ T-regulatory cell development and function.

Yujie Liu1, Liqing Wang1, Rongxiang Han1, Ulf H Beier2, Tatiana Akimova1, Tricia Bhatti3, Haiyan Xiao2, Philip A Cole4, Paul K Brindle5, Wayne W Hancock6.   

Abstract

T-regulatory (Treg) cells are important to immune homeostasis, and Treg cell deficiency or dysfunction leads to autoimmune disease. A histone/protein acetyltransferase (HAT), p300, was recently found to be important for Treg function and stability, but further insights into the mechanisms by which p300 or other HATs affect Treg biology are needed. Here we show that CBP, a p300 paralog, is also important in controlling Treg function and stability. Thus, while mice with Treg-specific deletion of CBP or p300 developed minimal autoimmune disease, the combined deletion of CBP and p300 led to fatal autoimmunity by 3 to 4 weeks of age. The effects of CBP and p300 deletion on Treg development are dose dependent and involve multiple mechanisms. CBP and p300 cooperate with several key Treg transcription factors that act on the Foxp3 promoter to promote Foxp3 production. CBP and p300 also act on the Foxp3 conserved noncoding sequence 2 (CNS2) region to maintain Treg stability in inflammatory environments by regulating pCREB function and GATA3 expression, respectively. Lastly, CBP and p300 regulate the epigenetic status and function of Foxp3. Our findings provide insights into how HATs orchestrate multiple aspects of Treg development and function and identify overlapping but also discrete activities for p300 and CBP in control of Treg cells.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25154413      PMCID: PMC4386456          DOI: 10.1128/MCB.00919-14

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  54 in total

1.  Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticity.

Authors:  Noriko Komatsu; Maria Encarnita Mariotti-Ferrandiz; Ying Wang; Bernard Malissen; Herman Waldmann; Shohei Hori
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-27       Impact factor: 11.205

2.  Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression.

Authors:  Hong Ma; Cu Nguyen; Kyung-Soon Lee; Michael Kahn
Journal:  Oncogene       Date:  2005-05-19       Impact factor: 9.867

3.  Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells.

Authors:  Ye Zheng; Steven Z Josefowicz; Arnold Kas; Tin-Tin Chu; Marc A Gavin; Alexander Y Rudensky
Journal:  Nature       Date:  2007-01-21       Impact factor: 49.962

4.  Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces.

Authors:  Yuri P Rubtsov; Jeffrey P Rasmussen; Emil Y Chi; Jason Fontenot; Luca Castelli; Xin Ye; Piper Treuting; Lisa Siewe; Axel Roers; William R Henderson; Werner Muller; Alexander Y Rudensky
Journal:  Immunity       Date:  2008-04       Impact factor: 31.745

5.  The structural basis of protein acetylation by the p300/CBP transcriptional coactivator.

Authors:  Xin Liu; Ling Wang; Kehao Zhao; Paul R Thompson; Yousang Hwang; Ronen Marmorstein; Philip A Cole
Journal:  Nature       Date:  2008-02-14       Impact factor: 49.962

6.  STAT6 Inhibits TGF-beta1-mediated Foxp3 induction through direct binding to the Foxp3 promoter, which is reverted by retinoic acid receptor.

Authors:  Hiromi Takaki; Kenji Ichiyama; Keiko Koga; Takatoshi Chinen; Giichi Takaesu; Yuki Sugiyama; Shigeaki Kato; Akihiko Yoshimura; Takashi Kobayashi
Journal:  J Biol Chem       Date:  2008-04-09       Impact factor: 5.157

7.  Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells.

Authors:  Seung G Kang; Hyung W Lim; Ourania M Andrisani; Hal E Broxmeyer; Chang H Kim
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

Review 8.  Structure and chemistry of the p300/CBP and Rtt109 histone acetyltransferases: implications for histone acetyltransferase evolution and function.

Authors:  Ling Wang; Yong Tang; Philip A Cole; Ronen Marmorstein
Journal:  Curr Opin Struct Biol       Date:  2008-10-27       Impact factor: 6.809

9.  Histone acetyltransferase CBP is vital to demarcate conventional and innate CD8+ T-cell development.

Authors:  Tomofusa Fukuyama; Lawryn H Kasper; Fayçal Boussouar; Trushar Jeevan; Jan van Deursen; Paul K Brindle
Journal:  Mol Cell Biol       Date:  2009-05-11       Impact factor: 4.272

10.  Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo.

Authors:  Xuyu Zhou; Samantha L Bailey-Bucktrout; Lukas T Jeker; Cristina Penaranda; Marc Martínez-Llordella; Meredith Ashby; Maki Nakayama; Wendy Rosenthal; Jeffrey A Bluestone
Journal:  Nat Immunol       Date:  2009-07-26       Impact factor: 25.606

View more
  35 in total

Review 1.  Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease.

Authors:  Michel DuPage; Jeffrey A Bluestone
Journal:  Nat Rev Immunol       Date:  2016-02-15       Impact factor: 53.106

2.  Regulatory T Cell Modulation by CBP/EP300 Bromodomain Inhibition.

Authors:  Srimoyee Ghosh; Alexander Taylor; Melissa Chin; Hon-Ren Huang; Andrew R Conery; Jennifer A Mertz; Andres Salmeron; Pranal J Dakle; Deanna Mele; Alexandre Cote; Hari Jayaram; Jeremy W Setser; Florence Poy; Georgia Hatzivassiliou; Denise DeAlmeida-Nagata; Peter Sandy; Charlie Hatton; F Anthony Romero; Eugene Chiang; Thornik Reimer; Terry Crawford; Eneida Pardo; Venita G Watson; Vickie Tsui; Andrea G Cochran; Laura Zawadzke; Jean-Christophe Harmange; James E Audia; Barbara M Bryant; Richard T Cummings; Steven R Magnuson; Jane L Grogan; Steve F Bellon; Brian K Albrecht; Robert J Sims; Jose M Lora
Journal:  J Biol Chem       Date:  2016-04-07       Impact factor: 5.157

3.  Maternal obesity impairs skeletal development in adult offspring.

Authors:  Jin Ran Chen; Oxana P Lazarenko; HaiJun Zhao; Alexander W Alund; Kartik Shankar
Journal:  J Endocrinol       Date:  2018-07-26       Impact factor: 4.286

4.  Hepatic stellate cells increase the immunosuppressive function of natural Foxp3+ regulatory T cells via IDO-induced AhR activation.

Authors:  Sudhir Kumar; Jiang Wang; Angus W Thomson; Chandrashekhar R Gandhi
Journal:  J Leukoc Biol       Date:  2016-08-31       Impact factor: 4.962

Review 5.  Regulatory T Cell Plasticity and Stability and Autoimmune Diseases.

Authors:  Runze Qiu; Liyu Zhou; Yuanjing Ma; Lingling Zhou; Tao Liang; Le Shi; Jun Long; Dongping Yuan
Journal:  Clin Rev Allergy Immunol       Date:  2020-02       Impact factor: 8.667

6.  CREB-binding protein regulates lung cancer growth by targeting MAPK and CPSF4 signaling pathway.

Authors:  Zhipeng Tang; Wendan Yu; Changlin Zhang; Shilei Zhao; Zhenlong Yu; Xiangsheng Xiao; Ranran Tang; Yang Xuan; Wenjing Yang; Jiaojiao Hao; Tingting Xu; Qianyi Zhang; Wenlin Huang; Wuguo Deng; Wei Guo
Journal:  Mol Oncol       Date:  2015-11-05       Impact factor: 6.603

Review 7.  CREB signals as PBMC-based biomarkers of cognitive dysfunction: A novel perspective of the brain-immune axis.

Authors:  Nancy Bartolotti; Orly Lazarov
Journal:  Brain Behav Immun       Date:  2019-01-12       Impact factor: 7.217

Review 8.  Histone/protein deacetylase inhibitor therapy for enhancement of Foxp3+ T-regulatory cell function posttransplantation.

Authors:  L Wang; U H Beier; T Akimova; S Dahiya; R Han; A Samanta; M H Levine; W W Hancock
Journal:  Am J Transplant       Date:  2018-04-21       Impact factor: 8.086

9.  The Curcumin Analog GO-Y030 Controls the Generation and Stability of Regulatory T Cells.

Authors:  Takashi MaruYama; Shuhei Kobayashi; Hiroko Nakatsukasa; Yuki Moritoki; Daiki Taguchi; Yoichi Sunagawa; Tatsuya Morimoto; Atsuko Asao; Wenwen Jin; Yuji Owada; Naoto Ishii; Yoshiharu Iwabuchi; Akihiko Yoshimura; WanJun Chen; Hiroyuki Shibata
Journal:  Front Immunol       Date:  2021-06-23       Impact factor: 7.561

Review 10.  Treg: A Promising Immunotherapeutic Target in Oral Diseases.

Authors:  Yujing Zhang; Jihua Guo; Rong Jia
Journal:  Front Immunol       Date:  2021-06-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.